Experimental groups | Treatments |
---|---|
1 | Crude antimicrobial substance (CAS) 8% |
2 | CAS 4% |
3 | B. subtilis ATCC 6633 |
4 | Vegetative form of C. perfringens |
5 | Spore form of C. perfringens |
6 | Germinated spore form of C. perfringens |
7 | C. perfringens enterotoxin (CPE) (1 μg/mL) |
8 | CPE+ B. subtilis ATCC 6633 |
9 | CPE+ CAS 4% |
10 | Vegetative form of C. perfringens + B. subtilis ATCC 6633 |
11 | Vegetative form of C. perfringens + CAS 4% |
12 | Spore form of C. perfringens + B. subtilis ATCC 6633 |
13 | Spore form of C. perfringens + CAS 4% |
14 | Germinated spore form of C. perfringens + B. subtilis ATCC 6633 |
15 | Germinated spore form of C. perfringens + CAS 4% |